Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis-Reference-Cited by-同舟云学术

Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis

Published:2022-04 Issue: Volume:98 Page:53-60
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Labenz Christian,Toenges Gerrit,Zheng Ming-Hua,Ding Dora,Myers Robert P.,Galle Peter R.,Armandi Angelo,Ampuero Javier,Gómez Manuel Romero,Bugianesi Elisabetta,Anstee Quentin M.,Schattenberg Jörn M.

Funder

Innovative Medicines Initiative

Gilead Sciences

European Federation of Pharmaceutical Industries and Associations

European Commission

Publisher

Elsevier BV

Subject

Internal Medicine

Reference27 articles.

1. Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: a cost-of-illness analysis;Schattenberg;Liver Int,2021

2. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis;Taylor;Gastroenterology,2020

3. Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study;O’Hara;JHEP Rep,2020

4. Refining noninvasive diagnostics in nonalcoholic fatty liver disease: closing the gap to detect advanced fibrosis;Schattenberg;Hepatology,2019

5. Reading the stars for hepatic fibrosis or how to predict the severity of liver disease in patients with NASH;Schattenberg;Liver Int,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence Applications in Hepatology;Clinical Gastroenterology and Hepatology;2023-07

2. Predicting liver-related events in NAFLD: A predictive model;Hepatology;2023-03-31

3. Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis;Alimentary Pharmacology & Therapeutics;2023-01-17

4. A non-invasive score for nonalcoholic fatty liver disease (NAFLD) cirrhosis;European Journal of Internal Medicine;2022-04